News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
The incidence of GEP-NETs in the US
hhmglobal.com
Jan 19, 2025, 07:23

The incidence of GEP-NETs in the US

JAMA Oncology posted on X about recent paper by Yazan Abboud et al., titled “Gastroenteropancreatic Neuroendocrine Tumor Incidence by Sex and Age in the US”.

Authors: Yazan Abboud, Anand Shah, Riya Sutariya, Vraj P. Shah, Ahmed Al-Khazraji, Paul J. Gaglio, Kaveh Hajifathalian

The incidence of GEP-NETs in the US

“The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the US has increased over the past two decades, particularly in the appendix, pancreas, and small intestine.”

Ahmed Al-Khazraji Anand Shah cancer Gastroenteropancreatic Neuroendocrine Tumors JAMA Oncology Kaveh Hajifathalian OncoDaily Oncology Paul J. Gaglio Riya Sutariya Vraj P. Shah Yazan Abboud
Special Coverage
Blog
Jun 4, 2025, 00:35
Ruben Mesa: Important work in Pharmacogenomics around DPYD at ASCO25
Blog
Jun 4, 2025, 00:12
Dinesh Raj Neupane: Paying the Price for Distance: Travel-Driven Financial Toxicity Among Cancer Patients in Nepal
Blog
Jun 3, 2025, 20:49
Tracey O’Brien: Excited to Announce Speakers for the Inaugural NSW Cancer Summit 2025
Insight
Jun 3, 2025, 18:29
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Insight
Jun 3, 2025, 18:25
From Political Will to Global Wake-Up Call: Hesham ElGhazaly on Egypt’s National Cancer Strategy at ASCO 2025
Insight
Jun 3, 2025, 18:19
Clifford Hudis and Thomas Kurian Discussed AI in Oncology and ASCO Guidelines Assistant at ASCO 2025
Insight
Jun 3, 2025, 18:18
Elizabeth McKenna: Study on Vascular Normalization and Enhanced Immunotherapy
Insight
Jun 3, 2025, 17:25
Mohammad Jad Moussa: Huge Congrats to My Future Co-Resident Sam Black on This ASCO 2025 Feat
Insight
Jun 3, 2025, 17:21
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Insight
Jun 3, 2025, 16:58
Paolo Tarantino Presented DATO-Base Trial Poster at ASCO 2025 on Breast Cancer CNS Metastases
Insight
Jun 3, 2025, 16:39
Pashtoon Kasi: This Is the 1st Time I Started Hearing the Word “CURE” in Patients with Metastatic Stage-IV Cancers
Blog
Jun 3, 2025, 16:39
Massimo Di Maio: Standing Ovation for CHALLENGE phase 3 trial at ASCO25